Genistein as a regulator of signaling pathways and microRNAs in different types of cancers

[1]  Weifeng Huang,et al.  Involvement of SIRT1 in Amelioration of Schistosomiasis-Induced Hepatic Fibrosis by Genistein. , 2021, Acta tropica.

[2]  V. Vodnik,et al.  Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines. , 2021, Materials science & engineering. C, Materials for biological applications.

[3]  Zhinan Mei,et al.  Genistein suppresses allergic contact dermatitis through regulating the MAP2K2/ERK pathway. , 2021, Food & function.

[4]  O. Abdallah,et al.  Oral Genistein-loaded Phytosomes with Enhanced Hepatic Uptake, Residence and Improved Therapeutic Efficacy against Hepatocellular Carcinoma. , 2021, International journal of pharmaceutics.

[5]  F. Guo,et al.  PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells. , 2021, Colloids and surfaces. B, Biointerfaces.

[6]  Jian Xiang,et al.  Genistein exerts a cell-protective effect via Nrf2/HO-1/PI3K signaling in Aβ25-35-induced Alzheimer's disease models in vitro. , 2021, Folia histochemica et cytobiologica.

[7]  P. Horcajada,et al.  Improving the genistein oral bioavailability via its formulation into the metal-organic framework MIL-100(Fe). , 2021, Journal of materials chemistry. B.

[8]  G. Galleri,et al.  Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption via Intestinal Lymphatic Transport , 2021, Pharmaceutics.

[9]  Jaana M. Hartikainen,et al.  Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.

[10]  Y. Moreau,et al.  Current cancer driver variant predictors learn to recognize driver genes instead of functional variants , 2021, BMC Biology.

[11]  Kitboklang Khongsti,et al.  MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells. , 2020, Life sciences.

[12]  Guoqing Yang,et al.  Involvement of α7nAChR in the Protective Effects of Genistein Against β-Amyloid-Induced Oxidative Stress in Neurons via a PI3K/Akt/Nrf2 Pathway-Related Mechanism , 2020, Cellular and Molecular Neurobiology.

[13]  Qian Zhang,et al.  Soy isoflavone genistein inhibits hsa_circ_0031250/miR‐873‐5p/FOXM1 axis to suppress non‐small‐cell lung cancer progression , 2020, IUBMB life.

[14]  S. Choudhury,et al.  Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  Fu Wang,et al.  Targeting miRNAs by natural products: A new way for cancer therapy. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Weifeng Huang,et al.  Genistein protects against acetaminophen-induced liver toxicity through augmentation of SIRT1 with induction of Nrf2 signalling. , 2020, Biochemical and biophysical research communications.

[17]  Jing Gao,et al.  Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of JAK1/2-STAT3 and AKT/MDM2/p53 signaling pathways , 2020, Aging.

[18]  K. Malekzadeh,et al.  Synthesizing efficacious genistein in conjugation with superparamagnetic Fe3O4 decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma , 2020, Biomaterials Research.

[19]  E. Karimi,et al.  Synthesis and characterisation of chitosan-encapsulated genistein: its anti-proliferative and anti-angiogenic activities , 2020, Journal of microencapsulation.

[20]  Peiqian Yang,et al.  Genistein inhibited the proliferation of kidney cancer cells via CDKN2a hypomethylation: role of abnormal apoptosis , 2020, International Urology and Nephrology.

[21]  Jing Jiang,et al.  Genistein Enhances Radiosensitivity of Human Hepatocellular Carcinoma Cells by Inducing G2/M Arrest and Apoptosis , 2020, Radiation Research.

[22]  V. Mukund.  Genistein: Its role in breast cancer growth and metastasis. , 2020, Current drug metabolism.

[23]  Samir Mitragotri,et al.  Materials for oral delivery of proteins and peptides , 2019, Nature Reviews Materials.

[24]  A. Balapure,et al.  Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis. , 2019, Life sciences.

[25]  M. Dieci,et al.  Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives , 2019, Cancers.

[26]  Wenxiang Cheng,et al.  Genistein inhibits angiogenesis developed during rheumatoid arthritis through the IL-6/JAK2/STAT3/VEGF signalling pathway , 2019, Journal of orthopaedic translation.

[27]  Yung-Hyun Choi,et al.  Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway , 2019, Antioxidants.

[28]  Sunday A Shoyele,et al.  Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates , 2019, Nanomaterials.

[29]  R. Holcombe,et al.  Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study , 2019, Cancer Chemotherapy and Pharmacology.

[30]  Ximing J. Yang,et al.  Genistein treatment duration effects biomarkers of cell motility in human prostate , 2019, PloS one.

[31]  Yi Sun,et al.  The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways. , 2019, Cell reports.

[32]  W. Fan,et al.  The role and mechanisms of action of microRNAs in cancer drug resistance , 2019, Clinical Epigenetics.

[33]  C. Emiliani,et al.  Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies , 2019, Journal of functional biomaterials.

[34]  S. Singh,et al.  An Overview on Genistein and its Various Formulations , 2018, Drug Research.

[35]  Qian Zhang,et al.  Genistein-triggered anticancer activity against liver cancer cell line HepG2 involves ROS generation, mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of cell migration , 2018, Archives of medical science : AMS.

[36]  Xingwang Zhang,et al.  Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs , 2018, Pharmaceutics.

[37]  Jie Zhu,et al.  Genistein inhibits invasion and migration of colon cancer cells by recovering WIF1 expression. , 2018, Molecular medicine reports.

[38]  Xueqi Fu,et al.  Co-administration of genistein with doxorubicin-loaded polypeptide nanoparticles weakens the metastasis of malignant prostate cancer by amplifying oxidative damage. , 2018, Biomaterials science.

[39]  W. Qi,et al.  Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway , 2017, BMC Cancer.

[40]  Xiangyu Hao,et al.  Folate Receptor-targeted Bioflavonoid Genistein-loaded Chitosan Nanoparticles for Enhanced Anticancer Effect in Cervical Cancers , 2017, Nanoscale Research Letters.

[41]  Jaehwi Lee,et al.  Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes , 2017, Biomolecules & therapeutics.

[42]  Zhenxiang Zhao,et al.  Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs , 2017, Inflammation.

[43]  Nitya V. Sharma,et al.  Effects of genistein supplementation on genome-wide DNA methylation and gene expression in patients with localized prostate cancer , 2017, International journal of oncology.

[44]  S. Santoso,et al.  Genistein modulates the estrogen receptor and suppresses angiogenesis and inflammation in the murine model of peritoneal endometriosis , 2017, Journal of traditional and complementary medicine.

[45]  M. Leveritt,et al.  Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol , 2017, BMC Cancer.

[46]  Rodney D. Priestley,et al.  Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier. , 2016, International journal of pharmaceutics.

[47]  Hetal Thakkar,et al.  Effect of particle size on oral bioavailability of darunavir-loaded solid lipid nanoparticles , 2016, Journal of microencapsulation.

[48]  Jinchao Zhang,et al.  Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling. , 2016, Oncology letters.

[49]  C. Walsh,et al.  Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer , 2016, The Prostate.

[50]  M. Al-Maghrebi,et al.  Genistein alleviates testicular ischemia and reperfusion injury-induced spermatogenic damage and oxidative stress by suppressing abnormal testicular matrix metalloproteinase system via the Notch 2/Jagged 1/Hes-1 and caspase-8 pathways. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[51]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[52]  G. Calin,et al.  Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein , 2016, Nutrition and cancer.

[53]  J. Qin,et al.  Genistein Inhibits Human Colorectal Cancer Growth and Suppresses MiR-95, Akt and SGK1 , 2015, Cellular Physiology and Biochemistry.

[54]  Zhiwei Wang,et al.  Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. , 2014, Current pharmaceutical design.

[55]  Y. Dodurga,et al.  Genistein-induced mir-23b expression inhibits the growth of breast cancer cells , 2014, Contemporary oncology.

[56]  R. Dahiya,et al.  Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells , 2014, British Journal of Cancer.

[57]  Zhiwei Wang,et al.  Genistein down-regulates miR-223 expression in pancreatic cancer cells. , 2013, Current drug targets.

[58]  Yongxiang Yin,et al.  Oncogenic MicroRNA-27a is a target for genistein in ovarian cancer cells. , 2013, Anti-cancer agents in medicinal chemistry.

[59]  Rajvir Dahiya,et al.  Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR , 2013, PloS one.

[60]  L. Castellano,et al.  MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression , 2013, Bioarchitecture.

[61]  R. Dahiya,et al.  Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells , 2013, British Journal of Cancer.

[62]  M. Periyasamy,et al.  miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts , 2013, Nucleic acids research.

[63]  Hong Chen,et al.  DNA Methylation and Histone Modifications of Wnt Genes by Genistein During Colon Cancer Development , 2013, Carcinogenesis.

[64]  R. Dahiya,et al.  Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer , 2013, PloS one.

[65]  B. Bao,et al.  Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. , 2012, Current drug targets.

[66]  F. Sarkar,et al.  Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151 , 2012, PloS one.

[67]  Wenbin Zhou,et al.  Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. , 2012, International journal of molecular medicine.

[68]  Guangchuang Yu,et al.  Genistein‐induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study , 2012, Proteomics.

[69]  E. Messing,et al.  A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients , 2012, Cancer Prevention Research.

[70]  Yukun Zhang,et al.  Genistein, an epigenome modifier during cancer prevention , 2011, Epigenetics.

[71]  Hong Chen,et al.  Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line , 2011, Experimental biology and medicine.

[72]  J. Khan,et al.  CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression , 2011, Cell Death and Differentiation.

[73]  Hong Chen,et al.  Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. , 2010, Anticancer research.

[74]  Taous Khan,et al.  MicroRNAs: synthesis, mechanism, function, and recent clinical trials. , 2010, Biochimica et biophysica acta.

[75]  N. Saarinen,et al.  Estrogen‐induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo , 2010, International journal of cancer.

[76]  R. Dahiya,et al.  Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. , 2010, Cancer research.

[77]  Bin Wang,et al.  Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. , 2009, Oncology reports.

[78]  Y. Yamori,et al.  Genistein suppresses adipogenesis of 3T3‐L1 cells via multiple signal pathways , 2009, Phytotherapy research : PTR.

[79]  Yi Wen Kong,et al.  How do microRNAs regulate gene expression? , 2008, Biochemical Society transactions.

[80]  Ying Su,et al.  Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells. , 2008, Carcinogenesis.

[81]  Xinru Wang,et al.  Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells , 2008, Cell Biology and Toxicology.

[82]  R. Park,et al.  Genistein protects pancreatic β cells against cytokine-mediated toxicity , 2007, Molecular and Cellular Endocrinology.

[83]  Y. Choi,et al.  Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery , 2007, Archives of pharmacal research.

[84]  W. V. Berghe,et al.  A Critical Role for p53 in the Control of NF-κB-Dependent Gene Expression in TLR4-Stimulated Dendritic Cells Exposed to Genistein1 , 2007, The Journal of Immunology.

[85]  Jing Qin,et al.  Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[86]  Zhiwei Wang,et al.  Retracted: Inhibition of nuclear factor κb activity by genistein is mediated via Notch‐1 signaling pathway in pancreatic cancer cells , 2006, International journal of cancer.

[87]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[88]  Young Joon Lee,et al.  The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. , 2004, Toxicology.

[89]  Yiwei Li,et al.  Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells , 2003, Oncogene.

[90]  Mengsu Yang,et al.  Inhibitory actions of genistein in human breast cancer (MCF-7) cells. , 2003, Biochimica et biophysica acta.

[91]  F. Sarkar,et al.  Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[92]  Bruno Fonseca-Santos,et al.  Formulating SLN and NLC as innovative drug delivery systems for non-invasive routes of drug administration. , 2019, Current medicinal chemistry.

[93]  Yajie Yin,et al.  Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways. , 2018, American journal of translational research.

[94]  M. Valadares,et al.  Preparation and characterization of solid oral dosage forms containing soy isoflavones , 2013 .

[95]  Yu Xiao.  Effects of genistein and VEGFR on proliferation of ECV304 cells , 2004 .

[96]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..